Brinavess

Medicinal product

(Invented) name

Brinavess

Active substance (s)

Vernakalantas

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01BG11, Vernakalant

Marketing authorisation holder

Advanz Pharma Limited, Airija

Date of authorisation

2010-09-01

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Vernakalantas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
42629	56397	1056397	flakonas	10 ml N1		Receptinis	EU/1/10/645/001	Netiekiama	-	-	No	-	-
42630	56398	1056398	flakonas	25 ml N1		Receptinis	EU/1/10/645/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-09-01	Registruotas